Stay updated with breaking news from Pharming Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Leiden, The Netherlands, February 8, 2024: Pharming Group N.V. announces that Pharming’s management will participate in the following investor conferences in the month of February: Oppenheimer...
Pharming Group (NASDAQ:PHAR – Get Free Report)’s share price gapped down prior to trading on Thursday . The stock had previously closed at $12.93, but opened at $11.80. Pharming Group shares last traded at $11.80, with a volume of 751 shares changing hands. Pharming Group Stock Performance The stock has a market capitalization of $805.32 […]
Shares of Pharming Group (NASDAQ:PHAR – Get Free Report) gapped up prior to trading on Wednesday . The stock had previously closed at $12.00, but opened at $12.72. Pharming Group shares last traded at $12.72, with a volume of 442 shares trading hands. Pharming Group Stock Down 2.6 % The stock has a market capitalization […]
Shares of Pharming Group (NASDAQ:PHAR – Get Free Report) gapped up prior to trading on Wednesday . The stock had previously closed at $12.00, but opened at $12.72. Pharming Group shares last traded at $12.72, with a volume of 442 shares changing hands. Pharming Group Price Performance The company has a debt-to-equity ratio of 0.62, […]
In its Phase 3 test, Ionis Pharmaceuticals drug donidalorsen reduced the frequency of swelling attacks caused by the rare disease hereditary angioedema. If Ionis can commercialize this drug, competition would include products from Takeda Pharmaceutical and BioCryst Pharmaceuticals.